Data Type
Cell Information
(858)
Citations
(4902)
FAQ
(515)
Culture Media
(69)
Category
Primary Cells and Media
(211)
Transfection
(164)
Laboratory Instrumentation
(70)
Endotoxin Detection
(54)
Bioassay
(43)
Electrophoreses and Analysis
(32)
Mycoplasma Detection and Prevention
(31)
Serum-free and Speciality Media
(16)
Cell Lines and Primary Cancer Cells
(7)
3D Cell Culture
(6)
Classical Media and Reagents
(6)
Cell Services
(3)
Bioprocess Containers
(2)
Informatics for QC Microbiology
(2)
Live Cell Imaging
(2)
Uncategorized
(2)
Protozoa
(1)
+ Show All
Research Area
Basic Research
(141)
Cancer Research/Cell Biology
(84)
Immunotherapy / Hematology
(63)
Gene Expression
(56)
Endotoxin Testing
(50)
Uncategorized
(45)
Stem Cells
(40)
Neurobiology
(27)
Cardiovascular
(26)
Respiratory Research
(26)
Molecular Biology
(25)
Regenerative medicine
(20)
Toxicology
(20)
Dermatology/Tissue Engineering
(13)
Drug Discovery
(7)
Gastroenterology
(1)
Parasitology
(1)
+ Show All
515 results sorted by
relevance
alphabetical
newest first
oldest first
W
h
a
t
i
s
t
h
e
a
m
o
u
n
t
o
f
s
i
R
N
A
n
e
e
d
e
d
p
e
r
N
u
c
l
e
o
f
e
c
t
i
o
n
®
R
e
a
c
t
i
o
n
?
When performing siRNA-mediated knockdown experiments it is advisable to conduct a dose-response (concentration) analysis to determine the minimum siRNA concentration necessary for sufficient target knockdown on the mRNA, protein, or functional level....
W
h
a
t
p
r
o
t
o
c
o
l
s
h
o
u
l
d
I
u
s
e
f
o
r
N
u
c
l
e
o
f
e
c
t
i
o
n
®
o
f
p
a
t
i
e
n
t
d
e
r
i
v
e
d
b
l
o
o
d
s
a
m
p
l
e
s
,
e
.
g
.
l
e
u
k
e
m
i
a
o
r
l
y
m
p
h
o
m
a
c
e
l
l
s
?
Unfortunately, we do not have a ready-to-use protocol for Chronic lymphocytic leukemia (CLL) or other blood cell derived cancer cells. The cells often have a chromosomal aberration and show the properties of a cell line. Therefore we suggest to...
A
r
e
r
a
t
a
n
d
m
o
u
s
e
h
e
p
a
t
o
c
y
t
e
s
t
r
a
n
s
f
e
c
t
e
d
b
y
N
u
c
l
e
o
f
e
c
t
i
o
n
®
s
t
i
l
l
f
u
n
c
t
i
o
n
a
l
?
Yes, transfected mouse hepatocytes show albumin synthesis rates comparable to those of untransfected cells. Moreover the morphology and polarization of rat hepatocytes is not affected by Nucleofection®.
W
h
i
c
h
p
i
p
e
t
t
e
t
i
p
s
a
r
e
c
o
m
p
a
t
i
b
l
e
w
i
t
h
t
h
e
9
6
-
w
e
l
l
S
h
u
t
t
l
e
®
N
u
c
l
e
o
c
u
v
e
t
t
e
®
P
l
a
t
e
s
?
We recommend using special tips, e.g. epT.I.P.S™ (Eppendorf, Hamburg, Germany) or TallTips™ (Matrix Technologies, Hudson, NH, USA). You can contact our Scientific Support Team for a list of compatible tips, including tips for pipetting robots.
C
a
n
I
f
r
e
e
z
e
t
h
e
9
6
-
w
e
l
l
N
u
c
l
e
o
c
u
v
e
t
t
e
®
P
l
a
t
e
s
?
Yes. Freezing of the plates at -20°C does not alter their properties.
C
a
n
I
i
n
t
e
g
r
a
t
e
t
h
e
9
6
-
w
e
l
l
S
h
u
t
t
l
e
®
D
e
v
i
c
e
i
n
t
o
a
l
i
q
u
i
d
h
a
n
d
l
i
n
g
s
y
s
t
e
m
?
Yes. The 96-well Shuttle® Device is designed in such a way that it is addressable by robot grippers. Furthermore, the software contains the required interface to be connected with the LHS software. However, the practical implementation for each...
C
a
n
I
u
s
e
t
h
e
N
u
c
l
e
o
f
e
c
t
o
r
®
2
b
S
o
l
u
t
i
o
n
s
a
n
d
O
p
t
i
m
i
z
e
d
P
r
o
t
o
c
o
l
s
w
i
t
h
t
h
e
4
D
-
N
u
c
l
e
o
f
e
c
t
o
r
®
X
-
U
n
i
t
o
r
t
h
e
9
6
-
w
e
l
l
S
h
u
t
t
l
e
®
D
e
v
i
c
e
?
No. The 4D-Nucleofector and 96-well Shuttle® System uses specifically optimized electrical parameters and solutions. Five different 4D-Nucleofector or 96-well Shuttle® Solutions are available for primary cells. For cell lines, three...
G
e
n
e
r
a
t
i
o
n
o
f
a
s
t
a
b
l
e
c
e
l
l
l
i
n
e
:
A
p
o
s
i
t
i
v
e
c
o
n
t
r
o
l
p
l
a
s
m
i
d
w
o
r
k
s
,
b
u
t
I
c
a
n
n
o
t
o
b
t
a
i
n
s
t
a
b
l
e
c
l
o
n
e
s
w
i
t
h
m
y
c
o
n
s
t
r
u
c
t
o
f
i
n
t
e
r
e
s
t
.
W
h
a
t
c
o
u
l
d
b
e
t
h
e
r
e
a
s
o
n
?
One reason could be that your gene product is toxic to the cells. We recommend testing the construct for expression of the gene of interest by transient Nucleofection® of your cells. If the proportion of expressing cells drops between 4 and 48 hours...
H
o
w
l
o
n
g
d
o
e
s
i
t
t
a
k
e
t
o
o
b
t
a
i
n
s
t
a
b
l
e
t
r
a
n
s
f
e
c
t
a
n
t
s
?
Depending on individual cell type and doubling rate, selection of stable transfectants will take between 7 and 28 days. Expansion and characterization of single cell clones will take several weeks in addition.
C
a
n
I
u
s
e
a
N
u
c
l
e
o
f
e
c
t
o
r
®
I
o
r
N
u
c
l
e
o
f
e
c
t
o
r
®
2
b
D
e
v
i
c
e
t
o
g
e
t
h
e
r
w
i
t
h
t
h
e
9
6
-
w
e
l
l
S
h
u
t
t
l
e
®
D
e
v
i
c
e
?
No, the 96-well Shuttle® only works in conjunction with the Nucleofector® IIs Device or our 4D-Nucleofector® Device.
PREVIOUS
PAGE
5
PAGE
6
PAGE
7
PAGE
8
PAGE
9
PAGE
10
PAGE
11
PAGE
12
PAGE
13
NEXT